ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO801

Adherence to a Low-Protein Diet (LPD) Is Associated with Slower Rate of eGFR Decline in Patients with CKD

Session Information

Category: Health Maintenance, Nutrition, and Metabolism

  • 1300 Health Maintenance, Nutrition, and Metabolism

Authors

  • Angeletti, Andrea, Sant'Orsola-Malpighi Hospital, Bologna, Italy
  • Zappulo, Fulvia, Sant'Orsola-Malpighi Hospital, Bologna, Italy
  • Fribourg, Miguel, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Farouk, Samira S., Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Guglielmo, Chiara, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Andrighetto, Sofia, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Hartzell, Susan, Icahn School of Medicine at Mount Sinai, New York, New York, United States
  • Cantarelli, Chiara, Università di Parma, Parma, Italy
  • Manrique, Joaquin, Complejo Hospital de Navarra, Pamplona, Spain
  • La Manna, Gaetano, Sant'Orsola-Malpighi Hospital, Bologna, Italy
  • Cravedi, Paolo, Icahn School of Medicine at Mount Sinai, New York, New York, United States
Background

LPD is considered an effective strategy to defer transition to dialysis in patients with CKD through azotemia reduction. However, whether dietary protein intake impacts the rate of kidney function decline remains controversial.

Methods

We included 135 patients with an eGFR between 20 and 60 mL/min/1.73m2 who started LPD (0.6-0.7g/kg/d) between 2015 and 2017 and retrospectively collected clinical history (diabetes status and RAASi therapy), serial eGFR (CKD-EPI), proteinuria, and urinary phosphorus. Dietary energy intake was >30Kcal/Kg/d. eGFR and 24h proteinuria were collected at the time of LPD initiation and at 6 and 12mo before and after LPD initiation.These time points were used to generate eGFR slopesbefore and after starting LPD. Adherence to LPD was estimated based on phosphaturia at 6mo after starting LPD. Patients on immunosuppressive therapy were excluded.

Results

There was a significant decrease in the rate of eGFR decline after LPD initiation (eGFR slopes: -0.35 ± 0.007 vs. -0.02 ± 0.003 ml/min/1.73m2/month before vs. after LPD; p = 0.0007) (Fig. 1), though proteinuria did not significantly change. Univariate analyses showed that phosphaturia was the only variable significantly (p = 0.05) associated with rate of eGFR change, while diabetes status, RAASi therapy, and proteinuria at baseline were not. In a multivariate analyses, phosphaturia retained an independent association.

Conclusion

This retrospective, single center study shows that adherence to LPD is independently associated with ameliorated kidney function decline. These data support strategies to increase patient adherence to LPD. Further studies are needed to elucidate mechanisms by which LPD exerts renoprotection.

Fig. 1. Average eGFR at different time points before and after low-protein diet initiation. Grey dots represent single patients.